Zdrovia Logo

Neurotoxins · Comparison

Daxxify vs Botox

Daxxify's selling point is duration: in its trials, the median time for frown lines to return was about six months, against the three to four months typical for Botox. It is dosed at 40 units for glabellar lines against 20 for Botox. Daxxify is FDA-approved in the US, but we could not find a Health Canada authorization as of October 2026, so Canadian clinics can't offer it yet.

Product facts checked October 2026 · By the Zdrovia team

Daxxify vs Botox Cosmetic at a glance

DaxxifyBotox Cosmetic
MoleculedaxibotulinumtoxinAonabotulinumtoxinA
MakerRevanceAllergan Aesthetics (AbbVie)
Labeled glabellar dose40 units20 units
Units per Botox unitAbout 2:1 by labeled glabellar doseReference product
OnsetOften 1–2 daysUsually 3–5 days
DurationAbout 6 months (median in trials)About 3–4 months
Storage before useRoom temperature before reconstitutionRefrigerated (2–8 °C) before and after reconstitution
Accessory proteinsNo (stabilised with a peptide, not human albumin)Yes (complexing proteins)
Status in CanadaNot found in Health Canada's database as of October 2026Authorized

Onset and duration are typical reported ranges. Units are product-specific and not interchangeable; the ratio is a planning reference from labeled glabellar doses.

Why Daxxify lasts longer

Daxxify (daxibotulinumtoxinA) is stabilised with a proprietary peptide rather than human albumin and contains no complexing proteins. The manufacturer attributes its longer duration to that formulation. In the phase 3 trials, the median duration of effect for glabellar lines was about 24 weeks.

Longer duration means fewer visits a year, which patients like and which changes the economics for a clinic: fewer appointments per patient, at a higher price per treatment.

Units and dose

The labeled glabellar dose is 40 units of Daxxify against 20 units of Botox, so a two-to-one ratio is the usual starting reference. As with every toxin, Daxxify's units are its own and aren't interchangeable with any other product.

Availability in Canada

We couldn't find Daxxify in Health Canada's Drug Product Database in October 2026. Patients who have read about it can be told it isn't available here yet. The authorized options in Canada are Botox Cosmetic, Dysport, Xeomin, Nuceiva (Jeuveau), Letybo and, since September 2026, the short-acting type E toxin Boey.

Daxxify to Botox units

BotoxDaxxify (planning reference)
20 units Botox≈40 units Daxxify
24 units Botox≈48 units Daxxify
40 units Botox≈80 units Daxxify
64 units Botox≈128 units Daxxify

Convert any dose, and compare every brand side by side, with the neurotoxin unit converter. For reference doses by area, see how many units of Botox by area.

What it costs in Canada

Daxxify isn't available in Canada as far as we could find, so there are no Canadian prices to compare. For the products that are, the median published price is $10 a unit across 16 clinics: see Botox pricing in Canada.

Questions

Is Daxxify available in Canada?

We could not find a Health Canada authorization for Daxxify as of October 2026. Check Health Canada's Drug Product Database for the current status.

How long does Daxxify last compared with Botox?

The median duration in Daxxify's trials was about six months, against the three to four months typical of Botox. Individual results vary.

How many units of Daxxify equal Botox?

The labeled glabellar dose is 40 units of Daxxify against 20 units of Botox, so about two Daxxify units per Botox unit is the usual starting reference.

More comparisons: Dysport vs Botox · Xeomin vs Botox · Jeuveau (Nuceiva) vs Botox · Boey, the new short-acting toxin

Record the brand with every unit

Zdrovia charts neurotoxin treatments by product, units, area, lot and expiry, with lot-tracked injectable inventory, so a switch between brands is never ambiguous in the record. Free for solo injectors, with data stored in Canada. See Zdrovia for medical spas.

Start freeSee injectable inventory